Citation Impact
Citing Papers
Preclinical Activity of Nanoliposomal Irinotecan Is Governed by Tumor Deposition and Intratumor Prodrug Conversion
2014
GEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis
2019 Standout
Phase III Study of Afatinib or Cisplatin Plus Pemetrexed in Patients With Metastatic Lung Adenocarcinoma With EGFR Mutations
2013 Standout
Translational Impact of Nanoparticle–Drug Conjugate CRLX101 with or without Bevacizumab in Advanced Ovarian Cancer
2014
Preclinical Efficacy of Bevacizumab with CRLX101, an Investigational Nanoparticle–Drug Conjugate, in Treatment of Metastatic Triple-Negative Breast Cancer
2016
Hypoxia‐inducible factors: coupling glucose metabolism and redox regulation with induction of the breast cancer stem cell phenotype
2016 StandoutNobel
Pharmacologic Targeting of Hypoxia-Inducible Factors
2019 StandoutNobel
Se-methylselenocysteine sensitizes hypoxic tumor cells to irinotecan by targeting hypoxia-inducible factor 1α
2010
Identification of a Novel Inhibitor of Mitogen-activated Protein Kinase Kinase
1998 Standout
Matrix metalloproteinases and the regulation of tissue remodelling
2007 Standout
Targeting hypoxia in cancer therapy
2011 Standout
Estrogen Receptors: How Do They Signal and What Are Their Targets
2007 Standout
Transdifferentiation of Rat Hepatic Stellate Cells Results in Leptin Expression
1998
Cancer nanomedicine: progress, challenges and opportunities
2016 Standout
Gastrointestinal stromal tumour
2007
Antiproliferative mechanism of retinoid derivatives in ovarian cancer cells
2001
The biology and management of non-small cell lung cancer
2018 StandoutNature
Lung Cancer
2008 Standout
Low-Density Lipoprotein Receptor-Related Protein-1 Mediates Endocytic Clearance of Tissue Inhibitor of Metalloproteinases-1 and Promotes Its Cytokine-Like Activities
2014 StandoutNobel
The tumour microenvironment after radiotherapy: mechanisms of resistance and recurrence
2015 Standout
Natural Pigments: Carotenoids, Anthocyanins, and Betalains — Characteristics, Biosynthesis, Processing, and Stability
2000 Standout
GSVA: gene set variation analysis for microarray and RNA-Seq data
2013 Standout
A New Role for TIMP-1 in Modulating Neurite Outgrowth and Morphology of Cortical Neurons
2009
Alternative Splicing and Promoter Usage Generates an Intracellular Stromelysin 3 Isoform Directly Translated as an Active Matrix Metalloproteinase
2002
Roadblocks to translational advances on metastasis research
2013
FGF signaling pathways in endochondral and intramembranous bone development and human genetic disease
2002 Standout
Lung cancer: current therapies and new targeted treatments
2016 Standout
Epilysin, a Novel Human Matrix Metalloproteinase (MMP-28) Expressed in Testis and Keratinocytes and in Response to Injury
2001
ErbBs in lung cancer
2008
Identification of Putative Target Genes of the Transcription Factor RUNX2
2013 StandoutNobel
Cell-free nucleic acids as biomarkers in cancer patients
2011 Standout
Structural Analysis and Promoter Characterization of the Human Collagenase-3 Gene (MMP13)
1997
Immune-mediated mechanisms influencing the efficacy of anticancer therapies
2015
Recent advances in MMP inhibitor design
2006
Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes
2005 StandoutNature
Oncogenic Mutations Counteract Intrinsic Disorder in the EGFR Kinase and Promote Receptor Dimerization
2012 StandoutNobel
Emerging Biological Principles of Metastasis
2017 Standout
Dual Regulation of Stromelysin-3 by Fibroblast Growth Factor-2 in Murine Osteoblasts
1998
Targeting metastasis
2016
A Simple Enantioconvergent and Chemoenzymatic Synthesis of Optically Active α‐Substituted Amides
2011 StandoutNobel
An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage
2014 Standout
Macrophages as regulators of tumour immunity and immunotherapy
2019 Standout
Clinical modes of EGFR tyrosine kinase inhibitor failure and subsequent management in advanced non-small cell lung cancer
2012
Tumor metastasis: mechanistic insights and clinical challenges
2006 Standout
Antiangiogenic therapy in oncology: current status and future directions
2016
Truncating mutations of hSNF5/INI1 in aggressive paediatric cancer
1998 StandoutNature
Secretory Mechanisms and Intercellular Transfer of MicroRNAs in Living Cells
2010 Standout
Neutrophils in cancer: neutral no more
2016 Standout
Circulating nucleic acids (CNAs) and cancer—A survey
2006
Met gene copy number predicts the prognosis for completely resected non‐small cell lung cancer
2008
Imatinib potentiates antitumor T cell responses in gastrointestinal stromal tumor through the inhibition of Ido
2011 StandoutNobel
VEGF in Signaling and Disease: Beyond Discovery and Development
2019 Standout
Topoisomerase IIα gene (TOP2A) amplification and deletion in cancer – more common than anticipated
2003
Hepatic Stellate Cells: Protean, Multifunctional, and Enigmatic Cells of the Liver
2008 Standout
New functions for the matrix metalloproteinases in cancer progression
2002 Standout
Matrix metalloproteinases in cancer: from new functions to improved inhibition strategies
2004
Hypoxia-inducible factors: mediators of cancer progression and targets for cancer therapy
2012 StandoutNobel
Matrix Metalloproteinases
1999 Standout
Remarkable Potential of the α-Aminophosphonate/Phosphinate Structural Motif in Medicinal Chemistry
2011
Incorporation of Iron Oxide Nanoparticles and Quantum Dots into Silica Microspheres
2008 StandoutNobel
Cellular retinol-binding protein-1 is transiently expressed in granulation tissue fibroblasts and differentially expressed in fibroblasts cultured from different organs.
1997
SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase
2001 Standout
Nuclear hormone receptors inhibit matrix metalloproteinase (MMP) gene expression through diverse mechanisms.
1996
MET As a Possible Target for Non–Small-Cell Lung Cancer
2013
Relative Abundance of EGFR Mutations Predicts Benefit From Gefitinib Treatment for Advanced Non–Small-Cell Lung Cancer
2011
Hypoxia-inducible factor 1 is a master regulator of breast cancer metastatic niche formation
2011 StandoutNobel
Degradable Controlled-Release Polymers and Polymeric Nanoparticles: Mechanisms of Controlling Drug Release
2016 Standout
Nanotechnology for Multimodal Synergistic Cancer Therapy
2017 Standout
Hypoxia-inducible factor 1-dependent expression of adenosine receptor 2B promotes breast cancer stem cell enrichment
2018 StandoutNobel
Copper-Catalyzed Synthesis of Mixed Alkyl Aryl Phosphonates
2014 StandoutNobel
Collagenase 3 Is a Target of Cbfa1, a Transcription Factor of the runt Gene Family Involved in Bone Formation
1999
Chemotherapy induces enrichment of CD47 + /CD73 + /PDL1 + immune evasive triple-negative breast cancer cells
2018 StandoutNobel
Cytogenetic and molecular analysis of a t(1;22)(p36;q11.2) in a rhabdoid tumor with a putative homozygous deletion of chromosome 22
1998
In Vivo Evidence That the Stromelysin-3 Metalloproteinase Contributes in a Paracrine Manner to Epithelial Cell Malignancy
1998
Targeting Receptor Tyrosine Kinase MET in Cancer: Small Molecule Inhibitors and Clinical Progress
2013
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
Matrix Metalloproteinase Inhibitors and Cancer—Trials and Tribulations
2002 StandoutScience
The Fibronectin Domain ED-A Is Crucial for Myofibroblastic Phenotype Induction by Transforming Growth Factor-β1
1998 Standout
Liquid Biopsies: Genotyping Circulating Tumor DNA
2014 Standout
Direct Interactions between Corepressors and Coactivators Permit the Integration of Nuclear Receptor-Mediated Repression and Activation
2002
Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases
2003 Standout
Reactive oxygen species generating systems meeting challenges of photodynamic cancer therapy
2016 Standout
Ultra-fast synthesis of magnetic and luminescent silica beads for versatile bioanalytical applications
2005
Structural Basis of Type II Topoisomerase Inhibition by the Anticancer Drug Etoposide
2011 StandoutScience
Microsatellite Instability as a Biomarker for PD-1 Blockade
2016
Works of Éric Guérin being referenced
Marked Activity of Irinotecan and Rapamycin Combination toward Colon Cancer Cells In vivo and In vitro Is Mediated through Cooperative Modulation of the Mammalian Target of Rapamycin/Hypoxia-Inducible Factor-1α Axis
2009
In Vivo Topoisomerase I Inhibition Attenuates the Expression of Hypoxia-Inducible Factor 1α Target Genes and Decreases Tumor Angiogenesis
2011
Transcriptional Induction of Stromelysin-3 in Mesodermal Cells Is Mediated by an Upstream CCAAT/Enhancer-binding Protein Element Associated with a DNase I-hypersensitive Site
1999
Genetic heterogeneity in lung and colorectal carcinoma as revealed by microsatellite analysis in plasma or tumor tissue DNA
2003
MET Gene Copy Number in Non-small Cell Lung Cancer: Molecular Analysis in a Targeted Tyrosine Kinase Inhibitor Naïve Cohort
2008
Stromelysin-3 Induction and Interstitial Collagenase Repression by Retinoic Acid
1997
Acquired irinotecan resistance is accompanied by stable modifications of cell cycle dynamics independent of MSI status
2013
Dosing and scheduling influence the antitumor efficacy of a phosphinic peptide inhibitor of matrix metalloproteinases
2004
Structure and Promoter Characterization of the Human Stromelysin-3 Gene
1995
Modification of topoisomerase genes copy number in newly diagnosed childhood acute lymphoblastic leukemia
2003
Stromal Tumour of the Rectum: Laparoscopic Approach of a Rare Localization of GIST
2006
Prognostic Significance of Allelic Imbalance at the c-kit Gene Locus and c-kit Overexpression by Immunohistochemistry in Pediatric Osteosarcomas
2005
A Model of Postsurgical Advanced Metastatic Breast Cancer More Accurately Replicates the Clinical Efficacy of Antiangiogenic Drugs
2013
Use of Magnetic Beads for Plasma Cell-free DNA Extraction: Toward Automation of Plasma DNA Analysis for Molecular Diagnostics
2003